Identification of borderline thyroid tumors by gene expression array analysis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.24616PMID 19658182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRAF (V600E) mutation and the biology of papillary thyroid cancer

  2008cited by this paper
• BRAF(V600E) mutation and the biology of papillary thyroid cancer.

  2008cited by this paper
• Do Benign Thyroid Nodules Have Malignant Potential? An Evidence-Based Review

  2008cited by this paper
• Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy

  2008cited by this paper
• Increasing Incidence of Thyroid Cancer in the United States, 1973–2002Davies L, Welch HG (Dept of Veterans Affairs Med Ctr, White River Junction, Vt; Darmouth Med School, Hanover, NH) JAMA 295:2164–2167, 2006§

  2007cited by this paper
• The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer

  2007cited by this paper
• Increasing incidence of thyroid cancer in the United States, 1973-2002.

  2006cited by this paper
• RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.

  2006cited by this paper
• [Thyroid papillary carcinoma].

  2006cited by this paper
• Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma.

  2006cited by this paper
• Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions.

  2006cited by this paper
• Follicular variant of papillary thyroid carcinoma

  2006cited by this paper
• RET/PTC Rearrangement--a link between Hashimoto's thyroiditis and thyroid cancer...or not.

  2006cited by this paper
• Handling of thyroid follicular patterned lesions

  2005cited by this paper
• Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors

  2005cited by this paper
• Immunoexpression of HBME-1, High Molecular Weight Cytokeratin, Cytokeratin 19, Thyroid Transcription Factor-1, and E-cadherin in Thyroid Carcinomas

  2005cited by this paper
• [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma].

  2005cited by this paper
• Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential

  2005cited by this paper
• Thyroid intrafollicular neoplasia (TIN) as a precursor of papillary microcarcinoma.

  2005cited by this paper
• Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.

  2005cited by this paper
• Usefulness of HBME‐1, cytokeratin 19 and galectin‐3 immunostaining in the diagnosis of thyroid malignancy

  2005cited by this paper
• Using gene expression profiling to differentiate benign versus malignant thyroid tumors.

  2004cited by this paper
• BRAF mutations are associated with some histological types of papillary thyroid carcinoma

  2004cited by this paper
• Discrimination of Benign and Malignant Thyroid Nodules by Molecular Profiling

  2004cited by this paper
• Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)‐like nuclear alterations express molecular markers of PTC

  2004cited by this paper
• Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma.

  2004cited by this paper
• Gene Expression Profiling of Differentiated Thyroid Neoplasms

  2004cited by this paper
• Observer Variation in the Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma

  2004cited by this paper
• Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma.

  2003cited by this paper
• BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.

  2003cited by this paper
• Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma.

  2002cited by this paper
• Observer Variation of Encapsulated Follicular Lesions of the Thyroid Gland

  2002cited by this paper
• Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma.

  2002cited by this paper
• Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.

  2002influential reference
• Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

  2001cited by this paper
• Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma

  2001cited by this paper
• Guest Editorial: Two Proposals Regarding the Terminology of Thyroid Tumors

  2000cited by this paper
• Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours

  1996cited by this paper
• Follicular variant of papillary thyroid carcinoma. A clinicopathologic study

  1994cited by this paper
• Encapsulated Papillary Neoplasms of the Thyroid: A Study of 14 Cases Followed for a Minimum of 10 Years

  1987influential reference
• Thyroid papillary carcinoma. Pathological and philosophical controversies.

  1983cited by this paper
• Solitary thyroid nodule. 2. Selective approach to management.

  1981cited by this paper
• Observer Variation in Histologic Classification of Thyroid Cancer

  1978cited by this paper
• The solitary thyroid nodule.

  1973cited by this paper

• Case Report and Literature Review: Overexpression of HMGA in Concomitant Plurihormonal Tumor and Papillary Thyroid Carcinoma

  2025cites this paper
• High mobility group A protein-2 as a tumor cancer diagnostic and prognostic marker: a systematic review and meta-analysis

  2020influential citation
• Application of HMWCK, CK19 and Galectin-3 as Immuno Histochemical Markers in the differential diagnosis of thyroid lesions

  2020cites this paper
• What’s New in Thyroid Tumor Classification, the 2017 World Health Organization Classification of Tumours of Endocrine Organs

  2019cites this paper
• Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis

  2018cites this paper
• C Cell and Follicular Epithelial Cell Precursor Lesions of the Thyroid.

  2017cites this paper
• Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-lik

  2017cites this paper
• An enhanced topologically significant directed random walk in cancer classification using gene expression datasets

  2017cites this paper
• Endocrine Dysfunction in Neurofibromatosis Type 1 – An Update

  2016cites this paper
• An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis

  2016cites this paper
• Borderline and Precursor Lesions of Thyroid Neoplasms: A Missing Link

  2015cites this paper
• High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.

  2015cites this paper
• The Diagnostic Utility of Combination of HMGA2 and IMP3 qRT-PCR Testing in Thyroid Neoplasms

  2015cites this paper
• Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential

  2015cites this paper
• Diagnostic Value of CK 19 and HMWCK 34 BE 12 in Differentiation between Selected Thyroid Neoplasms

  2014cites this paper
• The role of genetic markers in the evaluation and management of thyroid nodules.

  2014cites this paper
• Crosstalk between Fibroblast Growth Factor (FGF) Receptor and Integrin through Direct Integrin Binding to FGF and Resulting Integrin-FGF-FGFR Ternary Complex Formation

  2013cites this paper
• Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing.

  2013cites this paper
• Usefulness of Molecular Biology in Follicular-Derived Thyroid Tumors: From Translational Research to Clinical Practice

  2013cites this paper
• Usefulness of ancillary methods for diagnosis, prognosis and targeted therapy in thyroid pathology.

  2013cites this paper
• TSH Increases Iodine Uptake by Thyroid Cancer Cells During BRAF Silencing

  2013cites this paper
• Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.

  2013cites this paper
• Cytopathological review of patients that underwent thyroidectomies based on the diagnosis of papillary thyroid carcinoma by fine needle aspiration cytology but were later found to have benign tumors by histopathology

  2013cites this paper
• DUSP 6 / MKP 3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells

  2013influential citation
• Structure-Function Relationship of the Ligand-Binding Domain of the Fibroblast Growth Factor Receptor

  2013cites this paper
• Borderline lesions in thyroid tumor classification and well-differentiated tumor of uncertain malignant potential

  2013cites this paper
• Clinical Management of Thyroid Cancer

  2013cites this paper
• DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.

  2013influential citation
• Morphological Changes of Follicular Cells in Hashimoto’s disease: A Possible Cause of Overdiagnosis in Cytology

  2013cites this paper
• Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means

  2013cites this paper
• Classification of thyroid follicular cell tumors: with special reference to borderline lesions.

  2012cites this paper
• Intercellular Adhesion Molecule-1 (ICAM-1) is Upregulated in Aggressive Papillary Thyroid Carcinoma

  2012cites this paper
• Encapsulated papillary thyroid carcinoma, follicular variant: A misnomer

  2012cites this paper
• Gene Expression Analysis by DNA Microarray in Papillary and Follicular Differentiated Thyroid Cancer

  2012cites this paper
• Advances in surgical therapy for thyroid cancer

  2011cites this paper
• HMGA2 Expression Analysis in Cytological and Paraffin-embedded Tissue Specimens of Thyroid Tumors by Relative Quantitative RT-PCR

  2011cites this paper
• Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas.

  2011cites this paper
• Update on the molecular signature of differentiated thyroid cancer: clinical implications and potential opportunities

  2011cites this paper
• Fibroblast growth factors and their receptors in cancer.

  2011cites this paper
• Encapsulated follicular thyroid tumor with equivocal nuclear changes, so‐called well‐differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal

  2011cites this paper
• Follicular-Patterned Tumors of the Thyroid: The Battle of Benign vs. Malignant vs. So-called Uncertain

  2011cites this paper
• Retinoid X receptor γ up‐regulation is correlated with dedifferentiation of tumor cells and lymph node metastasis in papillary thyroid carcinoma

  2011cites this paper
• Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.

  2011cites this paper
• Molecular classification of thyroid nodules using high-dimensionality genomic data.

  2010cites this paper
• Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas.

  2010cites this paper
• Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications.

  2010cites this paper
• Apport de la biologie moléculaire en pathologie thyroïdienne

  2010cites this paper